PDE4 inhibitors: potential protective effects in inflammation and vascular diseases

• Main Authors: Tianfei Fan (Author), Wenjing Wang (Author), Yao Wang (Author), Mingtang Zeng (Author), Yi Liu (Author), Shuyao Zhu (Author), Lin Yang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Phosphodiesterase 4 (PDE4) inhibitors are effective therapeutic agents for various inflammatory diseases. Roflumilast, apremilast, and crisaborole have been developed and approved for the treatment of chronic obstructive pulmonary disease psoriatic arthritis, and atopic dermatitis. Inflammation unde...